In the News
Could Revolutionary Gene-editing Technology End Cancer?
CRISPR, a revolutionary technology that can edit genetic mistakes, is getting attention and scrutiny. It could help get rid of diseases like cystic fibrosis, muscular dystrophy and even HIV and cancer.
The New York Times: The Crispr Quandary
A new gene-editing tool might create an ethical morass — or it might make revising nature seem natural.
QB3: Caribou Named the Winner of the Groundbreaking Science Award at the 2015 QB3 Awards
The QB3 Awards were created to recognize the highest level of achievement in life science entrepreneurship in the San Francisco Bay Area.
Forbes: Caribou, A CRISPR Genome-Editing Company, Is Going To Share Ideas With DuPont
Caribou, the genome engineering company spun off from Jennifer Doudna’s CRISPR lab at Berkeley three years ago, announced today that it has agreed to a cross-licensing deal with DuPont , the industrial-chemicals company.
Genome Web: DuPont, Caribou Biosciences Ink Strategic Alliance on CRISPR, Cross-License IP
DuPont and Caribou Biosciences today announced a strategic alliance focused on agricultural applications of CRISPR/Cas9 genome editing.